Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
147
datasets available to search
ShareScore release 0.9.0
Dataset results
147 results for “vildagliptin”
VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01528254. IPD Sharing: YES. Countries: 34. Publications: 5.
Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes
ClinicalTrials.gov study NCT01822548. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients
ClinicalTrials.gov study NCT02002221. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
ClinicalTrials.gov study NCT02145611. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT05359432. IPD Sharing: YES. Countries: 1. Publications: 5.
A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes
ClinicalTrials.gov study NCT00312130. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00380445. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00110240. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD
ClinicalTrials.gov study NCT03693560. IPD Sharing: NO. Countries: 1. Publications: 8.
Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01497522. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
ClinicalTrials.gov study NCT00616811. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin
ClinicalTrials.gov study NCT00396071. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)
ClinicalTrials.gov study NCT01541956. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00138567. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women
ClinicalTrials.gov study NCT01827280. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00351507. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00237237. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099892. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes
ClinicalTrials.gov study NCT01147276. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099931. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.